IDEXX follows positive earnings with acquisition of Animana

Shares of IDEXX Laboratories ($IDXX) rose nearly 5% to $141.67 last week following a string of good news. On Oct. 24, the diagnostics maker reported third-quarter net income of $52.1 million on sales of $383.5 million, handily beating analyst estimates. Sales in its companion animal division were up 13% over the same period a year ago, while its poultry, livestock, and dairy unit grew 14%. On Oct. 30, IDEXX added to its practice-management offerings by acquiring Netherlands-based Animana, which makes software for veterinary practices. The purchase price was not disclosed. Release

Suggested Articles

Payers are now holding up Spark's $850,000 gene therapy as an example of how innovative drug developers can help payers afford pricey new treatments.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…

On New Year’s Day, Sanofi and Boehringer Ingelheim closed a $12.5 billion asset swap that had been in the works for a year, giving the closely held Germany-…